Transasia-Erba Groups’ international haematology range backed by European R&D, now in Pune; sets up India’s first training institute for lab technologists at Panchgani near Pune

Product Launch - Transasia

Priced 25% below comparable options, new range to make world-class diagnostics affordable for masses

Pune, May 4, 2019: Transasia-Erba Group, India’s No. 1 In-vitro Diagnostic (IVD) Company and among the leading global players focused on emerging markets, today as part of its 40th-anniversary celebration announced that its international haematology range is now available in Pune. Backed by European R&D, the 3-Part Differential Analyzer (3PDA) to 5-Part Differential Analyzer (5PDA) fully automated haematology analyzers, reagents and controls include a number of features to help institutions, clinicians and lab technologists offer an accurate diagnosis. Manufactured by Erba Lachema (100% owned subsidiary of Transasia) in Europe, the H 360, H 560 and ELite 580 haematology analyzers are widely used in the European and global market. Haematology analyzers are extensively used in patients and research settings to count and characterize blood cells for disease detection and monitoring. Basic analyzers return a complete blood count (CBC) with a three-part differential white blood cell (WBC) count. Sophisticated analyzers measure cell morphology and can detect small cell populations to diagnose rare blood conditions.

In addition to the routine parameters, the new haematology range offers additional parameters such as Platelet Large Cell Ratio (PLCR) and Platelet Large Cell Concentration (PLCC) that are reported by advanced automated haematology analyzers to add more insight to the possible causes of abnormal platelet counts. The instruments thus become particularly relevant for Pune, since there is a huge influx of rural masses from the nearby areas. It has been observed that a majority of these patients suffer from anaemia, thalassemia, sickle cell anaemia, haemophilia and other hemoglobinopathies.

Addressing the media, Suresh Vazirani, Chairman and Managing Director, Transasia Bio-Medicals Ltd., said, “We are glad to be introducing our haematology range, here today. In Maharashtra, Pune holds the distinction of having a well-developed healthcare infrastructure with a large number of specialized medical centres and hospitals. In fact, Pune is the only city in Maharashtra after Mumbai where Bone Marrow Transplant (BMT) is conducted. A BMT is critical for a large number of diseases of the blood. As a result, Pune attracts a lot of patients from nearby areas for BMT. A haematology analyzer plays a very important role in the diagnosis of blood infections and also in the treatment options. Also, there is something very interesting about the healthcare industry in Pune. Pune is home to a lot of global medical professionals who prefer using the latest technology. On the other hand, the patient population in Pune are conservative when it comes to spending on healthcare. So Doctors prefer to use technology which can be offered to patients at an affordable rate. And that is where we will be able to meet the gap with this new range of haematology analyzers. These instruments have been developed at our European subsidiary and are designed to meet the needs for affordable diagnostics for the Indian markets.”

“The diagnostics industry in India suffers from an acute shortage of skilled manpower. Instead of talking about it, we as a responsible industry and market leader went ahead and invested in setting up India’s first such specialized training institute in Panchgani near Pune” added Mr Vazirani.

India ranks 145th among 176 countries on the quality and accessibility of healthcare parameter. Limited access to quality medical infrastructure, including skilled manpower and technologies have been the pain points of over 70% of Indians who live in smaller towns and rural areas. Transasia has been focusing on indigenous development & technology adoption which facilitates affordable diagnostics through domestic manufacturing.
Talking about the newly launched range, Dr Preet KaurM.D. Pathology, Business Unit Head, Transasia said, “Accepted world-over for their quality, precision and ease-of-operation, the Erba range of haematology products will increase the adoption of automated haematology testing among Indian diagnostic labs. The range provides holistic solutions for clinical testing in general and targeted diagnostics which is an added advantage for pediatric and geriatric population. Other unique features include flagging of abnormal samples, RFID, large coloured LCD touch screen, customizable reporting formats, ability to connect to a Laboratory Information System (LIS) for result output and ready-to-use reagents that are cyanide free and environment-friendly. By addressing many challenges that labs and pathologists face, Transasia is helping healthcare professionals (HCPs) focus on giving patients the best possible care.”


Please enter your comment!
Please enter your name here